XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $872,000 | -0.3% | 214,286 | +10.5% | 0.00% | -100.0% |
| Q1 2021 | $875,000 | 0.0% | 194,005 | +9.1% | 0.00% | 0.0% |
| Q4 2020 | $875,000 | -31.0% | 177,831 | -16.8% | 0.00% | 0.0% |
| Q3 2020 | $1,268,000 | +108.6% | 213,863 | -6.4% | 0.00% | – |
| Q2 2020 | $608,000 | +322.2% | 228,472 | +209.3% | 0.00% | – |
| Q1 2020 | $144,000 | -78.2% | 73,874 | -21.4% | 0.00% | – |
| Q4 2019 | $662,000 | +3.4% | 93,968 | +44.3% | 0.00% | -100.0% |
| Q3 2019 | $640,000 | +2.1% | 65,119 | +18.9% | 0.00% | 0.0% |
| Q2 2019 | $627,000 | +17.0% | 54,773 | +2.7% | 0.00% | – |
| Q1 2019 | $536,000 | +9.6% | 53,339 | +85.4% | 0.00% | – |
| Q4 2018 | $489,000 | -7.0% | 28,762 | -3.9% | 0.00% | – |
| Q3 2018 | $526,000 | +27.7% | 29,923 | +37.9% | 0.00% | – |
| Q2 2018 | $412,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |